InvestorsHub Logo
Followers 30
Posts 2792
Boards Moderated 3
Alias Born 10/24/2015

Re: jondoeuk post# 913

Thursday, 05/19/2022 5:09:57 PM

Thursday, May 19, 2022 5:09:57 PM

Post# of 932
Preclinical posters

Engineering TGF-B-resistant TCR-edited T cells for mutant TP53-targeted cancer immunotherapy https://www.neogene.com/staging/wp-content/uploads/2022/04/Keystone-2022-TGFBR2-KO-TP53-R175H-TCR-poster-final-edit.pdf

Development of a personalized neoantigen specific TCR discovery platform https://www.neogene.com/staging/wp-content/uploads/2022/04/Neogene-Poster-v1-final_reduced.pdf